Fat metabolism research fragment
AOD-9604.
7 vendors · $40–89
Modified C-terminal fragment of human growth hormone (hGH 177–191). Researched for adipose-tissue mechanisms; not approved for human therapeutic use.
Live vendor register · grouped by strength
Every vendor. Cheapest per mg first, kits listed separately.
AOD-9604 · price per mg
7 listings · unflagged vendors first · Listings data last updated October 2026
Best price per mg: Hydro Research 5 mg at $8.00/mg.
5 mg
6 listings01
Hydro ResearchVID-HYDRO-RE · US dispatch · list $55 · Chromate content 5.75 mg/5 mg · 10-pack $350
5 mg
97.11%
Chromate RP-HPLC + LAL + metals (Oct 2025, below its own >98% spec) · Janoshik HPLC lot AOD3001 (Jun 2024, 99.1%) · sterility
In stock
Same/next-business-day dispatch · FedEx 2-Day
$8.00/mg
$40
02
Core PeptidesVID-CORE-PEP · US dispatch
5 mg
99%
Per-product COA (method unstated)
In stock
Same-day dispatch
$8.20/mg
$41
03
PepsupVID-PEPSUP · €34.99 · duties on delivery
5 mg
99%
No COA published (mfr claim 99%+)
In stock
NL dispatch · PostNL Tracked 2–5 business days
$8.20/mg
$41
04
Peptide ProsVID-PEPTIDE- · US dispatch · sale price
5 mg
99%
COA library (method unstated)
In stock
Same-day dispatch
$10.60/mg
$53
05
Direct PeptidesVID-DIRECT-P · US dispatch · single vial
5 mg
99.84%
UPLC-MS (BioRegen COA #12409, lot SYN-AOD5-0002, Mar 2026)
In stock
UPS Ground 2–5 business days (free)
$15.80/mg
$79
06
Vyal LabsVID-VYAL-LAB · US dispatch
5 mg
99%
COA by lot lookup (HPLC · MS) — no current batch shown
In stock
Same-day dispatch (before 2 PM EST) · 2–3 days
$17.80/mg
$89
Kits · multi-vial packs, price per vial
01
2 mgkit of 10
99%
HPLC · MS · Janoshik
In stock
3–7 days
$10.00/mg
$20≈ $200 per kit
Same research area
Similar compounds.
GH secretagogue research
Ipamorelin
Synthetic pentapeptide described in 1998 by Novo Nordisk researchers as a selective ghrelin/GH-secretagogue receptor agonist; researched for growth-hormone release. Not approved for human therapeutic use.
8 vendors$18–79
GHRH analogue research
CJC-1295
GHRH(1-29) analogue developed by ConjuChem; the DAC form binds albumin and persists for days, the no-DAC form (Mod GRF 1-29) is short-acting. Researched for GH/IGF-1 stimulation; not approved for human therapeutic use.
7 vendors$30–99
GIP/GLP-1 dual agonist research
Tirzepatide
Dual GIP/GLP-1 receptor agonist, FDA- and EMA-approved as Mounjaro and Zepbound. Research-vial tirzepatide is a different, unapproved product, not made or reviewed as those medicines, and not for human use.
7 vendors$69–105
Triple hormone agonist research
Retatrutide
Investigational triple GIP/GLP-1/glucagon receptor agonist (LY3437943) developed by Eli Lilly and studied in Phase 3 trials; not approved as a medicine anywhere and not for human therapeutic use.
7 vendors$79–165
GLP-1 receptor agonist research
Semaglutide
GLP-1 receptor agonist, FDA- and EMA-approved as Ozempic, Wegovy and Rybelsus. Research-vial semaglutide is a different, unapproved product, not made or reviewed as those medicines, and not for human use.
4 vendors$49–79
Amylin analogue research
Cagrilintide
Long-acting amylin-receptor agonist (AM833 / NNC0174-0833) developed by Novo Nordisk, studied alone and in the CagriSema combination; not approved as a medicine anywhere and not for human therapeutic use.
4 vendors$109–169
Long-form research guide
Weight Loss Research. Mechanism + protocols + safety.
Lipolysis, GH secretagogues, and adipose tissue modulation in obesity models
Open the long-form guide for AOD-9604 →